Watch for Downside Follow-Through<br />By Rev Shark<br />RealMoney.com Contributor<br />9/24/2009 9:24 AM EDT<br /><br />It may sound strange, but many champions are made champions by setbacks. -- Bob Richards<br /><br />Yesterday, for the first time in the last 15 days of trading, we had a weak close. Since Sept. 2, the market has had a parabolic ride without any meaningful pullback at all. The bulls have been extremely confident the whole way and have benefited greatly from a legion of skeptical, underinvested bulls that provide constant support, never seeming to have an easy opportunity to load up on the long side.<br /><br />On Wednesday we had one of those nasty "sell the news" reactions to rather benign news form the Fed. Nothing surprising was announced, and the initial reaction to the announcement was quite jubilant, but the selling kicked in, and the dip-buyers disappeared for once. We went straight down and closed at the lows of the day.<br /><br />In the bigger scheme of things, a two-hour-long selloff after a couple of weeks of going straight up isn't anything too worrisome. In fact, it probably is a healthy thing that we have a bout of profit-taking. There are lots of recent gains, and when folks lock some in, it helps to alleviate some of the building "overbought" technical pressure. When market players rack up gains in a straight up market, you have to expect that they will periodically take some money off the table.<br /><br />So overall there wasn't anything particularly unusual about a sudden bout of sell-the-news profit-taking. The issue is whether it was just a little hiccup within a very powerful uptrend or the start of something much more dramatic.<br /><br />This market has been so strong for so long that it can sell off another 5% or so without really impacting the prevailing trend. It isn't until we start approaching the 50-day simple moving average around 1008 that a real change in trend commences. That doesn't mean a more minor pullback won't be quite painful. A lot of folks will be heading for the sidelines rather quickly to protect gains if we don't show signs of a quick recovery. Momentum players who have been chasing this market will sell first and ask questions later, and that can help to generate some pretty fast downside moves.<br /><br />Of course, the dip-buyers have been the great strength of this market, and they will be the key in determining when this uptrend will end. They have not had any notable failures for weeks prior to yesterday afternoon, and they are very likely to stay aggressive in their pursuits. A real market turn won't come until this group of buyers loses some of its confidence and is unable to quickly and easily drive the market back up. It has been a very long time since the dip-buyers have shied away, and they are going to keep on trying until they suffer a few nasty losses. At some point, the trend will shift, and we will get a propensity to sell strength. There are no signs of that yet, but that is what we have to watch for.<br /><br />So we have one weak day after a very powerful run. It is premature to make too much about it, but it certainly is something to keep in mind. What we look for now is some downside follow-through. If the bulls can manage another weak day, then maybe we start questioning the health of this uptrend more. At this point, the negatives are still too minor to worry too much about, although some increased defensiveness is not a bad idea at all. <br />-----------------------------<br />Ülespoole avanevad:<br /><br />In reaction to strong earnings/guidance: COMS +7.3%, RHT +6.9% (upgraded to Buy at BofA/Merrill), CTAS +2.6% ... Select financial names showing strength: AIG +2.7%, FRE +2.5%, SNV +2.1%, GNW +1.9%, ING +1.4%, MS +1.3%, STT +1.0%... Select gold related names trading higher: NG +3.4%, AUY +2.3%, HMY +2.2%, KGC +2.1%, AEM +2.0%, AU +1.9%, GOLD +1.8%, IAG +1.8%, GG+1.6%, ABX +1.4%... Select casino related names showing strength: LVS +1.4%, MGM +1.3%... Other news: GNVC +18.4% (receives fourth-year funding from NIAID For HIV vaccine contract; will receive up to $2.3 mln for the fourth year), VICL +14.2% (presents positive preclinical results with Vaxfectin-formulated, peptide-based cancer vaccine), ONCY +13.9% (announces start of enrolment in U.S. Phase 2 melanoma cancer clinical trial), HLCS +13.2% (announces publication of first-ever direct sequencing of single molecules of RNA), CRXX +12.7% (FDA Advisory Committee hears presentations and public comment on EXALGO extended-release tablets), YRCW +3.4% (continued strength from yesterday's 30%+jump), C +1.8% (Citigroup will pare back to six major metro areas - WSJ), EQT +1.1% (Cramer makes positive comments on MadMoney)... Analyst comments: ARIA +4.9% (Leerink Swann sees increasing excitement surrounding ARIA's multi-kinase inhibitor), CTXS +4.4% (added to Conviction Buy list at Goldman- Reuters), MTH +4.2% (Goldman Sachs raises U.S. homebuilders sector to Attractive - Reuters), NSM +3.4% (upgraded to Buy at Citigroup), CPN +2.3% (upgraded to Buy at Citigroup), KLAC +1.5% (upgraded to Perform at Oppenheimer), APA +1.3% (upgraded to Overweight at Morgan Stanley).<br /><br />Allapoole avanevad:<br /><br />In reaction to disappointing earnings/guidance: CPRT -7.1%, WR -6.8% (also downgraded to Neutral at JPMorgan), RAD -5.1%, PAYX -3.0%, BBBY -2.4% (also downgraded to Neutral from Outperform at Credit Suisse)... M&A news: ERTS -1.6% (MSFT spokesperson says co has no plans to buy ERTS)... Select China related names ticking lower: CHL -1.6%, LFC -1.5%... Other news: CNXT -11.5% (announces that it intends to sell 7 mln shares of common stock), HERO -9.5% (announces 17.5 mln common share offering), PSEC -9.5% (to issue and sell ~2.81 mln shares of common stock at an aggregate offering price of $9.00 per share), PPS -6.1% (commenced a public offering of 3 mln shares of common stock), ARE -4.8% (is commencing an underwritten public offering of 3,000,000 shares of common stock), NMR -3.4% (Nomura Holdings plans $5.6 billion share sale - WSJ), BSDM -2.9% (filed for a $50 mln mixed shelf offering), ATPG -1.9% (prices 5.3 mln common share offering at $18.50/share), FFCH -1.8% (announces it has priced offering of 4,193,550 shares of common stock at price of $15.50/share), AZN -1.8% (still checking)... Analyst comments: ANN -3.6% (cut to Neutral from Buy at Goldman- DJ), UFS -2.6% (downgraded to Hold at Deutsche), MDRX -1.2% (downgraded to Market Perform from Outperform at Raymond James), CAH -1.2% (downgraded to Hold at Deutsche), HTS -1.0% ( downgraded to Market Perform from Outperform at JMP Securities).